Logo 659 (Ropinirole hydrochloride extended-release 4 mg)

Pill imprint Logo 659 has been identified as Ropinirole hydrochloride extended-release 4 mg.

Ropinirole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 4 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for Logo 659

Ropinirole hydrochloride extended-release 4 mg Logo 659
Ropinirole hydrochloride extended-release 4 mg Logo 659
Ropinirole hydrochloride extended-release
Imprint:
Logo 659
Strength:
4 mg
Color:
Blue
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Actavis Elizabeth LLC
National Drug Code (NDC):
00228-3659
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
castor oil
hypromelloses
lactose monohydrate
magnesium stearate
maltodextrin
titanium dioxide
ferrosoferric oxide
FD&C Yellow No. 6
FD&C Blue No. 2
polydextrose
polyvinyl alcohol
polyethylene glycol
triacetin

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)